Investor Relations

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area of oncology with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has promising product candidates in clinical and late preclinical development and has entered into strategic collaborations with leading global pharmaceutical companies.

Recent News > MORE
Date Title  
Wednesday, October 26, 2016 Five Prime Therapeutics to Present at the 25th Annual Credit Suisse Healthcare Conference
Thursday, October 20, 2016 Five Prime Therapeutics to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 3
Upcoming and Recent Events > MORE
Date Title  
Monday, November 7, 2016
2:00 PM MT
Credit Suisse 25th Annual Healthcare Conference
Location The Phoenician
Scottsdale , AZ
Thursday, November 3, 2016
4:30 PM ET
Five Prime Therapeutics, Inc. 2016 Q3 Quarterly Earnings Call
Monday, September 19, 2016
Five Prime Therapeutics Rings the NASDAQ Stock Market Opening Bell

FPRX (Common Stock)

Change (%)

Data as of 3:17 PM ET on Friday, October 28, 2016
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.